bioAffinity Technologies, Inc.

BIAF · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9-$8-$8-$6
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$4
Stock-Based Comp.$1$1$0$0
Change in WC$0$1$0$1
Other Non-Cash$0$0$4-$0
Operating Cash Flow-$7-$6-$4-$2
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0-$2$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$2-$0$0
Financing Activities
Debt Repay.-$0-$0$1$0
Stock Issued$4$0$6$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$8$3
Financing Cash Flow$6-$0$14$3
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$9$10$1
Supplemental Information
Beg. Cash$3$11$1$0
End Cash$1$3$11$1
Free Cash Flow-$7-$6-$4-$2